Pharmaceutical composition including ACE/NEP inhibitors and bioavailability enhancers

Details for Australian Patent Application No. 2002308494 (hide)

Owner Supernus Pharmaceuticals, Inc.

Inventors Chang, Rong-Kun; Burnside, Beth A.; Shojaei, Amir

Agent Spruson & Ferguson

Pub. Number AU-B-2002308494

PCT Number PCT/US02/13301

PCT Pub. Number WO2002/087621

Priority 60/287,535 30.04.01 US

Filing date 30 April 2002

Wipo publication date 11 November 2002

Acceptance publication date 19 April 2007

International Classifications

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/197 (2006.01)

A61K 31/198 (2006.01)

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4365 (2006.01)

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/08 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61K 47/28 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Steroids

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/287,535 30.04.01 US

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002308494

21 September 2006 Assignment before Grant

  Shire Laboratories, Inc. The application has been assigned to Supernus Pharmaceuticals, Inc.

19 April 2007 Application Accepted

  Published as AU-B-2002308494

16 August 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002308495-METHOD AND APPARATUS FOR DECREASING SIGNAL PROPAGATION DELAY IN A WAVEGUIDE

2002308493-GRATING-OUTCOUPLED SURFACEEMITTING LASERS USING QUANTUM WELLS